NMPA Approval

Lurasidone Hydrochloride Tablets

Approval Number

国药准字H20249367

Company丽珠集团丽珠制药厂

Registration Date

November 15, 2024

Drug Information

Generic Name

盐酸鲁拉西酮片

Dosage Form

片剂

Strength

40mg（按C₂₈H₃₆N₄O₂S·HCl计）

Drug Type

化学药品

Registration Date

November 15, 2024

Company Information

Applicant Company

Company Name丽珠集团丽珠制药厂

Company Address

珠海市金湾区创业北路38号

Manufacturing Company

Company Name丽珠集团丽珠制药厂

Company Address

珠海市金湾区创业北路38号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸鲁拉西酮片 - NMPA 批准文号 | MedPath